Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)
China flag China · Delayed Price · Currency is CNY
30.85
-0.01 (-0.03%)
Feb 13, 2026, 3:04 PM CST

SHE:002880 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
79.6274.76252.3294.59332.1471.57
Short-Term Investments
-153.3221.47---
Cash & Short-Term Investments
79.6428.08273.77294.59332.1471.57
Cash Growth
-81.30%56.36%-7.07%-11.30%-29.58%54.73%
Accounts Receivable
262.6284.26133.91208.46204.25246.67
Other Receivables
24.1117.085.054.651.620.53
Receivables
286.71301.34138.96213.11205.87247.2
Inventory
966.64793.46672.98605.51421.68383.92
Other Current Assets
12.414.7117.9819.9239.7119
Total Current Assets
1,3451,5281,1041,133999.361,122
Property, Plant & Equipment
619.86691.09683.191,045785.22565.3
Long-Term Investments
77.6777.6786.7283.4969.1718.95
Goodwill
19.2319.2319.2319.2319.2319.23
Other Intangible Assets
152.38134.91136.875.1176.2678.75
Long-Term Deferred Tax Assets
10.479.9710.542.733.073.17
Long-Term Deferred Charges
45.2628.3424.7522.7719.4118.73
Other Long-Term Assets
1,124808.65811.85194.6231.7910.32
Total Assets
3,3943,2972,8772,5762,0041,836
Accounts Payable
134.68137.1477.5533.1428.9724.1
Accrued Expenses
79.52135.98124.6675.5787.2566.91
Short-Term Debt
126.38111.4911.06100.092582
Current Portion of Long-Term Debt
48.5114.7424.15---
Current Portion of Leases
-1.641.461.321.39-
Current Income Taxes Payable
20.369.6811.345.0814.887.1
Current Unearned Revenue
7.630.763.27.82.42.57
Other Current Liabilities
43.7211.3312.576.767.261.8
Total Current Liabilities
460.81422.75265.99229.76167.15184.49
Long-Term Debt
495.64554.1483.71428.96--
Long-Term Leases
15.9315.3216.0816.6617.04-
Long-Term Unearned Revenue
47.8843.2746.7825.9223.9825.82
Long-Term Deferred Tax Liabilities
11.0911.7212.540.861.01-
Other Long-Term Liabilities
6.056.056.056.056.052.05
Total Liabilities
1,0371,053831.14708.2215.23212.36
Common Stock
226.8226.8226.8226.8226.8162
Additional Paid-In Capital
563.49563.49574.5574.5574.5639.3
Retained Earnings
1,5341,4211,2131,040967.42802.49
Total Common Equity
2,3242,2112,0141,8411,7691,604
Minority Interest
32.7732.8131.3626.7719.5519.99
Shareholders' Equity
2,3572,2442,0461,8681,7881,624
Total Liabilities & Equity
3,3943,2972,8772,5762,0041,836
Total Debt
686.47697.28536.46547.0243.4282
Net Cash (Debt)
-606.87-269.21-262.69-252.44288.68389.57
Net Cash Growth
-----25.90%27.82%
Net Cash Per Share
-2.68-1.19-1.16-1.111.271.72
Filing Date Shares Outstanding
226.8226.8226.8226.8226.8226.8
Total Common Shares Outstanding
226.8226.8226.8226.8226.8226.8
Working Capital
884.551,105837.72903.37832.2937.2
Book Value Per Share
10.259.758.888.127.807.07
Tangible Book Value
2,1522,0571,8581,7471,6731,506
Tangible Book Value Per Share
9.499.078.197.707.386.64
Buildings
-367.81341.65318.11269.13179.45
Machinery
-798.15701.71590.44516.79446.86
Construction In Progress
-42.2391.69536.42342.36268.22
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.